H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Agenus Incorporated | 2 | $177,729 | $160,000 - $195,458 | 100.0% |
| Travere Therapeutics, Inc. | 2 | $203,718 | $185,000 - $222,435 | 100.0% |
| BLUEPRINT MEDICINES CORPORATION | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| Jazz Pharmaceuticals, Inc. | 1 | $148,000 | $148,000 - $148,000 | 100.0% |
| Nurix Therapeutics | 1 | $140,000 | $140,000 - $140,000 | 100.0% |
| SK LIFE SCIENCE, INC. | 1 | $192,394 | $192,394 - $192,394 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 7 | $185,000 | $140,000 - $222,435 |
| Senior | 1 | $120,000 | $120,000 - $120,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Ashland | MA | 1 | $192,394 |
| Cambridge | MA | 1 | $120,000 |
| Erie | CO | 1 | $185,000 |
| Hopkinton | MA | 1 | $222,435 |
| Monrovia | MD | 1 | $140,000 |
| Somerset | NJ | 1 | $160,000 |
These roles are variations of Associate Director, Pharmacovigilance with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Associate Director, Pharmacovigilance | 9 | $173,207 | |
| SENIOR ASSOCIATE, PHARMACOVIGILANCE | 2 | $101,435 | |
| Associate Director, Pharmacovigilance QMS and Compliance | 1 | $140,000 | |
| Senior Associate, Pharmacovigilance Records & Compliance | 1 | $120,000 | |
| Associate Director Pharmacovigilance Operations & Compliance | 1 | $185,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 1 | $160,000 | 100.0% |
| 2022 | 1 | $120,000 | 100.0% |
| 2025 | 3 | $148,000 | 100.0% |
| 2026 | 3 | $192,394 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Agenus Incorporated | 2 | $177,729 | 100.0% |
| Travere Therapeutics, Inc. | 2 | $203,718 | 100.0% |
| BLUEPRINT MEDICINES CORPORATION | 1 | $120,000 | 100.0% |
| Jazz Pharmaceuticals, Inc. | 1 | $148,000 | 100.0% |
| Nurix Therapeutics | 1 | $140,000 | 100.0% |